Literature DB >> 4006306

Plasma membrane antigens on light density and activated human blood eosinophils.

P C Tai, D M Bakes, J R Barkans, C J Spry.   

Abstract

In order to study the membrane events which lead to human blood eosinophil activation and degranulation, six clone of mouse monoclonal antibodies were made to isolated blood eosinophils from a patient with the hypereosinophilic syndrome (HES). The antibodies were specific for the plasma membranes of blood eosinophils and neutrophils, eosinophil myelocytes and haemopoietic cell lines. A higher proportion of blood eosinophils from eight patients with the HES bound these antibodies compared to normal individuals. Five antibodies stained intermediate density eosinophils preferentially, and one stained the light density eosinophils most strongly. Normal blood eosinophils were induced to express more of these antigens either by culture alone (two antibodies) or culture with monocyte culture supernatant which activates eosinophils for increased cytotoxic capacity (four antibodies). It was concluded that several of the principal antigens on the eosinophil plasma membrane are also present on neutrophils and immature haemopoietic cells, and that their expression in mature blood eosinophils is related to the extent of eosinophil activation and degranulation. It is suggested that these antigens may be useful in studying the ways in which eosinophils alter their plasma membrane during activation and degranulation in vitro, and in the blood of patients with an eosinophilia.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4006306      PMCID: PMC1577022     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  33 in total

1.  EOSINOPHILIC LEUKEMIA: A MORPHOLOGIC AND HISTOCHEMICAL STUDY.

Authors:  G A ACKERMAN
Journal:  Blood       Date:  1964-10       Impact factor: 22.113

2.  Membrane receptors for IgG and complement (C4, C3b and C3d) on human eosinophils and neutrophils and their relation to eosinophilia.

Authors:  A R Anwar; A B Kay
Journal:  J Immunol       Date:  1977-09       Impact factor: 5.422

3.  A new method for the purification of human eosinophils and neutrophils, and a comparison of the ability of these cells to damage schistosomula of Schistosoma mansoni.

Authors:  M A Vadas; J R David; A Butterworth; N T Pisani; T A Siongok
Journal:  J Immunol       Date:  1979-04       Impact factor: 5.422

4.  Production of monospecific rabbit antihuman eosinophil serums and demonstration of a blocking phenomenon.

Authors:  A A Mahmoud; R W Kellermeyer; K S Warren
Journal:  N Engl J Med       Date:  1974-02-21       Impact factor: 91.245

5.  Antibodies to major histocompatibility antigens produced by hybrid cell lines.

Authors:  G Galfre; S C Howe; C Milstein; G W Butcher; J C Howard
Journal:  Nature       Date:  1977-04-07       Impact factor: 49.962

6.  Alkaline phosphatase and peroxidase for double immunoenzymatic labelling of cellular constituents.

Authors:  D Y Mason; R Sammons
Journal:  J Clin Pathol       Date:  1978-05       Impact factor: 3.411

7.  Eosinophil membrane changes during interaction with antibody-coated non-phagocytosable surfaces.

Authors:  K J Thorne; R C Oliver; A M Glauert
Journal:  Biochem Soc Trans       Date:  1981-02       Impact factor: 5.407

8.  Fc receptors for IgE on human and rat eosinophils.

Authors:  M Capron; A Capron; J P Dessaint; G Torpier; S G Johansson; L Prin
Journal:  J Immunol       Date:  1981-06       Impact factor: 5.422

9.  Enzymes altering the binding capacity of human blood eosinophils for IgG antibody-coated erythrocytes (EA).

Authors:  P C Tai; C J Spry
Journal:  Clin Exp Immunol       Date:  1980-04       Impact factor: 4.330

10.  Eosinophil interaction with antibody-coated, non-phagocytosable surfaces: changes in cell surface proteins.

Authors:  K J Thorne; R C Oliver; A M Glauert
Journal:  J Cell Sci       Date:  1980-04       Impact factor: 5.285

View more
  13 in total

Review 1.  Eosinophils. Assays and interpretation.

Authors:  D E Maddox
Journal:  Clin Rev Allergy       Date:  1988

2.  The effects of recombinant granulocyte-macrophage colony-stimulating factor (GM-CSF) and interleukin-3 on the secretory capacity of human blood eosinophils.

Authors:  P C Tai; C J Spry
Journal:  Clin Exp Immunol       Date:  1990-06       Impact factor: 4.330

3.  The effects of eosinophil activating factor on IgG-dependent sulphidopeptide leukotriene generation by human eosinophils.

Authors:  P Fitzharris; R Moqbel; K J Thorne; B A Richardson; A Hartnell; O Cromwell; A E Butterworth; A B Kay
Journal:  Clin Exp Immunol       Date:  1986-12       Impact factor: 4.330

Review 4.  Eosinophils as effector cells in immunity and hypersensitivity disorders.

Authors:  A B Kay
Journal:  Clin Exp Immunol       Date:  1985-10       Impact factor: 4.330

Review 5.  New properties and roles for eosinophils in disease: discussion paper.

Authors:  C J Spry
Journal:  J R Soc Med       Date:  1985-10       Impact factor: 5.344

6.  Shape changes, exocytosis, and cytosolic free calcium changes in stimulated human eosinophils.

Authors:  P Kernen; M P Wymann; V von Tscharner; D A Deranleau; P C Tai; C J Spry; C A Dahinden; M Baggiolini
Journal:  J Clin Invest       Date:  1991-06       Impact factor: 14.808

7.  Human eosinophils stimulate DNA synthesis and matrix production in dermal fibroblasts.

Authors:  T P Birkland; M D Cheavens; S H Pincus
Journal:  Arch Dermatol Res       Date:  1994       Impact factor: 3.017

8.  Expression of lacto-N-fucopentaose III (CD15)- and sialyl-Lewis X-bearing molecules and their functional properties in eosinophils from patients with the idiopathic hypereosinophilic syndrome.

Authors:  T Satoh; A Knowles; M S Li; L Sun; J A Tooze; G Zabucchi; C J Spry
Journal:  Immunology       Date:  1994-10       Impact factor: 7.397

9.  Monoclonal antibodies to human eosinophil plasma membrane antigens enhance the secretion of eosinophil cationic protein.

Authors:  P C Tai; M Capron; D M Bakes; J Barkans; C J Spry
Journal:  Clin Exp Immunol       Date:  1986-03       Impact factor: 4.330

10.  Autoreactive eosinophils associated with spontaneous autocytotoxicity in bronchial asthma.

Authors:  W K Podleski
Journal:  Agents Actions       Date:  1988-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.